A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients

Clinical trial NCT06254014 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06254014
Sponsor: Beijing Dongfang Biotech Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2024-07-10
Primary completion: 2026-05-01
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.